NASDAQ : IART

Integra LifeSciences Holdings Corporation — Financial statements

Healthcare · Medical Devices · United States

Last price 12.83 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 998.19M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Integra LifeSciences Holdings Corporation (IART) reported revenue of 1.66B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue1.66B1.64B1.61B1.54B1.56B1.54B
Cost of Revenue736.95M715.83M651.40M656.84M587.36M597.81M
Gross Profit919.84M919.42M959.12M884.74M970.31M944.64M
Selling, General & Admin659.13M676.12M665.53M656.64M616.32M637.45M
Research & Development81.88M82.43M97.43M104.19M101.19M93.05M
Amortization of Goodwill & Intangibles15.07M14.95M14.19M12.38M13.88M14.16M
Operating Expenses756.08M773.50M777.15M773.21M731.39M744.66M
Operating Income163.76M145.91M181.98M111.53M238.92M199.98M
Interest Expense-92.09M-86.25M-70.63M-51.38M-49.59M-50.40M
Interest & Investment Income17.74M18.47M20.04M17.20M11.92M6.74M
Currency Exchange Gain (Loss)18.04M-63.44M35.23M-4.40M3.30M
Other Non Operating Income (Expenses)-2.08M62.35M-30.98M8.12M8.71M19.31M
EBT Excluding Unusual Items105.36M77.05M135.63M81.07M213.25M175.63M
Merger & Restructuring Charges-15.77M-15.81M-4.95M
Impairment of Goodwill-511.37M
Gain (Loss) on Sale of Assets644.00K41.80M
Asset Writedown-11.70M-2.75M
Other Unusual Items-67.28M-113.38M-137.22M
Pretax Income22.31M-563.50M-18.24M81.07M213.89M214.68M
Income Tax Expense9.30M-47.03M-11.29M13.33M33.34M45.60M
Earnings From Continuing Operations13.01M-516.47M-6.94M67.74M180.55M169.07M
Net Income13.01M-516.47M-6.94M67.74M180.55M169.07M
Net Income to Common13.01M-516.47M-6.94M67.74M180.55M169.07M
Shares Outstanding (Basic)77.10M76.67M77.01M80.09M83.00M84.70M
Shares Outstanding (Diluted)77.65M76.67M77.01M80.34M83.52M85.48M
EPS (Basic)0.17-6.74-0.090.852.182.00
EPS (Diluted)0.17-6.74-0.090.842.161.98
Free Cash Flow85.78M-31.05M24.96M73.09M222.13M264.40M
Free Cash Flow Per Share1.10-0.410.320.912.663.09
Gross Margin55.52%56.23%59.55%57.39%62.29%61.24%
Operating Margin9.88%8.92%11.30%7.23%15.34%12.96%
Profit Margin0.78%-31.58%-0.43%4.39%11.59%10.96%
Free Cash Flow Margin5.18%-1.90%1.55%4.74%14.26%17.14%
EBITDA317.82M297.75M322.87M235.04M357.22M319.82M
EBITDA Margin19.18%18.21%20.05%15.25%22.93%20.73%
D&A For EBITDA154.06M151.83M140.89M123.51M118.30M119.84M
EBIT163.76M145.91M181.98M111.53M238.92M199.98M
EBIT Margin9.88%8.92%11.30%7.23%15.34%12.96%
Effective Tax Rate41.67%16.44%15.59%21.24%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents252.26M235.05M246.38M276.40M456.66M513.45M
Short-Term Investments59.67M28.69M27.19M32.69M
Cash & Short-Term Investments311.93M263.74M273.57M309.10M456.66M513.45M
Receivables248.99M278.85M272.37M259.33M263.46M243.24M
Inventory464.45M492.74M429.09M389.61M324.58M317.39M
Prepaid Expenses117.62M96.09M77.00M67.36M85.76M65.82M
Other Current Assets46.94M28.13M29.65M32.64M31.03M13.82M
Total Current Assets1.19B1.16B1.08B1.06B1.16B1.15B
Property, Plant & Equipment577.27M584.90M549.76M496.38M459.59M396.25M
Long-Term Investments6.34M12.75M38.30M30.71M40.03M4.37M
Goodwill607.83M615.16M1.10B1.06B1.04B1.01B
Other Intangible Assets1.04B1.13B1.21B1.07B1.13B1.15B
Long-Term Deferred Tax Assets66.71M69.85M34.92M46.08M45.99M56.95M
Other Long-Term Assets19.07M25.13M28.21M27.48M17.16M12.07M
Total Assets3.51B3.60B4.04B3.78B3.89B3.78B
Accounts Payable66.42M95.73M82.50M92.33M102.10M61.84M
Accrued Expenses151.18M164.50M169.74M144.71M147.32M186.64M
Short-Term Debt87.80M
Current Portion of Long-Term Debt49.36M39.85M607.76M15.11M38.12M63.19M
Current Portion of Leases14.59M14.02M14.54M15.28M14.62M14.78M
Current Income Taxes Payable1.70M3.65M
Current Unearned Revenue12.07M11.46M10.48M8.54M7.25M5.29M
Other Current Liabilities33.67M38.97M37.10M31.01M11.48M8.28M
Total Current Liabilities329.00M455.98M922.13M306.98M320.91M340.02M
Long-Term Debt1.78B1.73B1.20B1.49B1.41B1.53B
Long-Term Leases161.09M163.06M166.93M166.85M157.42M90.33M
Long-Term Unearned Revenue9.45M11.55M9.19M
Pension & Post-Retirement Benefits13.84M15.44M19.38M12.31M25.27M
Long-Term Deferred Tax Liabilities4.79M5.66M60.83M35.32M63.34M45.79M
Other Long-Term Liabilities158.64M178.36M120.46M179.31M126.19M64.84M
Total Liabilities2.44B2.56B2.49B2.19B2.09B2.10B
Common Stock921.00K923.00K916.00K909.00K905.00K896.00K
Additional Paid-In Capital1.35B1.34B1.32B1.30B1.28B1.26B
Retained Earnings438.16M423.44M939.91M946.86M879.12M698.57M
Treasury Stock-684.09M-689.21M-691.41M-647.26M-362.86M-234.45M
Comprehensive Income & Other-34.51M-30.08M-27.57M-15.11M10.27M-45.16M
Shareholders' Equity1.07B1.04B1.55B1.59B1.80B1.68B
Total Liabilities & Equity3.51B3.60B4.04B3.78B3.89B3.78B
Total Debt2.00B2.03B1.99B1.68B1.62B1.70B
Net Cash (Debt)-1.69B-1.77B-1.71B-1.37B-1.16B-1.19B
Net Cash Per Share-21.78-23.10-22.24-17.11-13.87-13.88
Filing Date Shares Outstanding77.80M77.94M77.22M78.22M81.64M83.24M
Total Common Shares Outstanding77.81M77.89M77.16M78.17M83.65M84.70M
Working Capital860.94M703.56M159.56M751.06M840.59M813.70M
Book Value Per Share13.7113.4020.0320.3121.5719.89
Tangible Book Value-581.85M-706.36M-759.26M-535.41M-361.09M-474.23M
Tangible Book Value Per Share-7.48-9.07-9.84-6.85-4.32-5.60
Land4.16M952.00K978.00K966.00K1.51M
Buildings78.31M19.75M14.86M14.71M19.03M
Machinery444.97M405.41M383.47M358.14M206.98M
Construction In Progress179.61M196.63M137.28M103.88M94.85M
Leasehold Improvements181.24M179.90M171.06M163.34M155.50M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income13.01M-516.47M-6.94M67.74M180.55M169.07M
Depreciation & Amortization154.06M151.83M140.89M123.51M118.30M119.84M
Other Amortization4.10M5.61M5.59M6.16M6.84M7.03M
Loss (Gain) From Sale of Assets2.21M490.00K1.50M777.00K-7.46M-39.56M
Asset Writedown & Restructuring Costs511.37M12.21M2.75M
Stock-Based Compensation19.75M18.58M24.38M20.14M27.73M36.21M
Other Operating Activities-17.82M-87.28M-17.23M3.19M-22.07M-1.08M
Change in Accounts Receivable12.12M-485.00K7.40M4.59M-33.91M7.26M
Change in Inventory16.94M-46.76M-28.15M-59.77M-29.12M5.37M
Change in Accounts Payable-15.51M26.72M-2.67M-20.23M17.34M32.87M
Change in Unearned Revenue-935.00K3.40M3.54M128.00K4.27M28.00K
Change in Other Net Operating Assets-47.52M-16.61M-11.12M-6.29M1.99M-27.38M
Operating Cash Flow140.40M50.38M129.38M139.96M264.47M312.43M
Capital Expenditures-54.62M-81.44M-104.42M-66.86M-42.34M-48.02M
Sale of Property, Plant & Equipment11.14M3.00K
Cash Acquisitions-277.81M-51.51M-303.91M
Divestitures23.96M190.47M
Sale (Purchase) of Intangibles-14.20M-14.20M-9.95M-4.74M-58.00K
Investment in Securities-23.98M-1.50M5.50M-32.69M
Other Investing Activities-10.49M-10.92M-4.13M5.38M4.91M76.00K
Investing Cash Flow-103.28M-108.06M-390.81M-94.18M-58.58M-161.44M
Long-Term Debt Issued720.70M486.50M165.10M40.75M25.50M
Long-Term Debt Repaid-669.89M-187.13M-110.60M-148.55M-125.50M
Net Debt Issued (Repaid)-6.05M50.81M299.37M54.50M-107.80M-100.00M
Issuance of Common Stock760.00K957.00K6.40M4.32M5.46M6.82M
Repurchase of Common Stock-1.93M-2.92M-55.98M-280.86M-149.62M-4.80M
Other Financing Activities-7.25M-20.52M-11.92M-7.88M-249.00K
Financing Cash Flow-14.47M28.34M237.86M-229.93M-251.95M-98.23M
Foreign Exchange Rate Adjustments-2.57M18.02M-6.46M3.89M-10.72M-9.48M
Net Cash Flow20.07M-11.33M-30.03M-180.26M-56.79M43.28M
Free Cash Flow85.78M-31.05M24.96M73.09M222.13M264.40M
Free Cash Flow Margin5.18%-1.90%1.55%4.74%14.26%17.14%
Free Cash Flow Per Share1.10-0.410.320.912.663.09
Levered Free Cash Flow106.28M44.46M90.15M84.87M165.64M377.40M
Unlevered Free Cash Flow159.74M92.77M128.70M110.82M189.79M401.87M
Cash Interest Paid81.40M81.40M64.40M44.30M42.20M43.20M
Cash Income Tax Paid17.20M17.20M22.70M23.60M35.90M49.50M
Change in Working Capital-34.91M-33.74M-31.01M-81.57M-39.42M18.16M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization991.96M967.42M1.75B3.40B4.68B5.67B
Enterprise Value2.68B2.71B3.46B4.80B5.87B6.92B
Last Close Price12.7512.4222.6843.5556.0766.99
PE Ratio75.9250.2625.9433.56
Forward PE5.475.218.8312.9416.1620.19
PS Ratio0.600.591.092.213.013.68
PB Ratio0.930.931.132.142.603.37
P/FCF Ratio11.5670.1046.5821.0821.46
P/OCF Ratio7.0719.2013.5324.3317.7118.16
PEG Ratio1.2418.376.171.541.681.36
EV/Sales Ratio1.621.662.153.113.774.49
EV/EBITDA Ratio8.449.0910.7320.4216.4421.63
EV/EBIT Ratio16.3918.5519.0443.0424.5834.59
EV/FCF Ratio31.28138.7565.6826.4426.16
Debt / Equity Ratio1.881.951.281.060.901.01
Debt / EBITDA Ratio5.836.335.726.504.255.00
Debt / FCF Ratio23.3579.5723.037.276.43
Net Debt / Equity Ratio1.591.701.110.870.640.70
Net Debt / EBITDA Ratio5.325.955.305.853.243.71
Net Debt / FCF Ratio19.72-57.0468.6118.805.224.49
Asset Turnover0.460.430.410.400.410.42
Inventory Turnover1.551.551.591.841.831.91
Quick Ratio1.711.190.591.852.242.23
Current Ratio3.622.541.173.453.623.39
Return on Equity (ROE)1.24%-39.90%-0.44%3.99%10.35%10.57%
Return on Assets (ROA)2.86%2.39%2.91%1.82%3.89%3.38%
Return on Invested Capital (ROIC)3.43%4.81%5.85%3.15%6.91%5.56%
Return on Capital Employed (ROCE)5.20%4.60%5.80%3.20%6.70%5.80%
Earnings Yield1.32%-53.39%-0.40%1.99%3.86%2.98%
FCF Yield8.65%-3.21%1.43%2.15%4.74%4.66%
Buyback Yield / Dilution-1.38%0.44%4.14%3.81%2.30%-0.30%